Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment (Q28301630)

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

Europe PubMed Central

title

Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment (English)

0 references

0 references

Christoph Heesen

1

0 references

Anders Romberg

series ordinal

2

0 references

Stefan Gold

series ordinal

3

0 references

Karl-Heinz Schulz

series ordinal

4

0 references

language of work or name

English

0 references

publication date

March 2006

0 references

published in

0 references

volume

6

0 references

issue

3

0 references

page(s)

347-55

0 references

cites work

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

The role of exercise prescription in chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Physical rehabilitation has a positive effect on disability in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Randomized controlled trial of yoga and exercise in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Endocrine and cytokine responses to standardized physical stress in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Exercise: a behavioral intervention to enhance brain health and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Psychosocial vs. "physical" stress situations in rodents and humans: role of neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Permeability of the blood-brain barrier to neurotrophins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Fitness effects on the cognitive function of older adults: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Cardiovascular fitness, cortical plasticity, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Exercise and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

What do people with MS want and expect from health-care services?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

A randomized controlled study of the acute and chronic effects of cooling therapy for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Cardiovascular fitness and neurocognitive function in older adults: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

The regulatory role of natural killer cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347

Recommendations for physical activity in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.347